4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001062993-23-013872
Chief Financial Officer sold 70,000 shares at $8.53 ($597,100)
- Chief Financial Officer acquired 14,328 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PETERSON TYCHO Chief Financial Officer | 2023-06-15 | Sale 10b5-1 | −55,672 | $8.53 | $474,882 | 399,219 | D: show line 1 in the form |
| PETERSON TYCHO Chief Financial Officer | 2023-06-15 | Option exercise 10b5-1 | +14,328 | $7.30 | $104,594 | 413,547 | D: show line 2 in the form |
| PETERSON TYCHO Chief Financial Officer | 2023-06-15 | Sale 10b5-1 | −14,328 | $8.53 | $122,218 | 399,219 | D: show line 3 in the form |
| Open-market sales · 70,000 sh · avg $8.53 · $597,100 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| PETERSON TYCHO Chief Financial Officer | 2023-06-15 | Option exercise · Stock Option (right to buy) 10b5-1 | −14,328 | 582,829 | D: show line 4 in the form |
Loading xslF345X04/form4.xml…